APO RESEARCH · REPORT
Recombinant Trypsin Solution
Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
Product & engineering
Understand the product.
Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
Selected research
Market Analysis & Forecast
Global Recombinant Trypsin Solution Market Analysis and Forecast 2026-2032
Market perspective
Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
Global Recombinant Trypsin Solution key players include Novozymes, BBI Group, etc. Global top two manufacturers hold a share about 57%.
North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 45 percent.
Read the full market overview
In terms of product, Liquid is the largest segment, with a share about 65%. And in terms of application, the largest application is Cell Culture, followed by Insulin Manufacturing, Vaccines Manufacturing, etc.
This report presents an overview of global market for Recombinant Trypsin Solution, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Recombinant Trypsin Solution, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Trypsin Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Trypsin Solution sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Trypsin Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Trypsin Solution sales, projected growth trends, production technology, application and end-user industry.
Recombinant Trypsin Solution Segment by Company
Novozymes
BBI Group
Roche
Thermo Fisher
Merck
Applied Biotechnology Institute
Biological Industries
Yaxin Bio
Yocon Hengye Bio
BasalMedia
Biosera
Recombinant Trypsin Solution Segment by Type
Solid
Liquid
Recombinant Trypsin Solution Segment by Application
Insulin Manufacturing
Vaccines Manufacturing
Cell Culture
Other
Recombinant Trypsin Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Trypsin Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Trypsin Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Trypsin Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Recombinant Trypsin Solution in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Recombinant Trypsin Solution manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Trypsin Solution sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid
- Liquid
Applications
- Insulin Manufacturing
- Vaccines Manufacturing
- Cell Culture
- Other
Companies covered
- Novozymes
- BBI Group
- Roche
- Thermo Fisher
- Merck
- Applied Biotechnology Institute
- Biological Industries
- Yaxin Bio
- Yocon Hengye Bio
- BasalMedia
- Biosera
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Recombinant Trypsin Solution Market by Type
- 1.2.1 Global Recombinant Trypsin Solution Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Solid
- 1.2.3 Liquid
- 1.3 Recombinant Trypsin Solution Market by Application
- 1.3.1 Global Recombinant Trypsin Solution Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Insulin Manufacturing
- 1.3.3 Vaccines Manufacturing
- 1.3.4 Cell Culture
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Recombinant Trypsin Solution Market Dynamics
- 2.1 Recombinant Trypsin Solution Industry Trends
- 2.2 Recombinant Trypsin Solution Industry Drivers
- 2.3 Recombinant Trypsin Solution Industry Opportunities and Challenges
- 2.4 Recombinant Trypsin Solution Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Recombinant Trypsin Solution Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Recombinant Trypsin Solution Revenue by Region
- 3.2.1 Global Recombinant Trypsin Solution Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Recombinant Trypsin Solution Revenue by Region (2021-2026)
- 3.2.3 Global Recombinant Trypsin Solution Revenue by Region (2027-2032)
- 3.2.4 Global Recombinant Trypsin Solution Revenue Market Share by Region (2021-2032)
- 3.3 Global Recombinant Trypsin Solution Sales Estimates and Forecasts 2021-2032
- 3.4 Global Recombinant Trypsin Solution Sales by Region
- 3.4.1 Global Recombinant Trypsin Solution Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Recombinant Trypsin Solution Sales by Region (2021-2026)
- 3.4.3 Global Recombinant Trypsin Solution Sales by Region (2027-2032)
- 3.4.4 Global Recombinant Trypsin Solution Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Recombinant Trypsin Solution Revenue by Manufacturers
- 4.1.1 Global Recombinant Trypsin Solution Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Recombinant Trypsin Solution Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Recombinant Trypsin Solution Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Recombinant Trypsin Solution Sales by Manufacturers
- 4.2.1 Global Recombinant Trypsin Solution Sales by Manufacturers (2021-2026)
- 4.2.2 Global Recombinant Trypsin Solution Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Recombinant Trypsin Solution Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Recombinant Trypsin Solution Sales Price by Manufacturers (2021-2026)
- 4.4 Global Recombinant Trypsin Solution Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Recombinant Trypsin Solution Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Recombinant Trypsin Solution Manufacturers, Product Type & Application
- 4.7 Global Recombinant Trypsin Solution Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Recombinant Trypsin Solution Market CR5 and HHI
- 4.8.2 2025 Recombinant Trypsin Solution Tier 1, Tier 2, and Tier 3
5 Recombinant Trypsin Solution Market by Type
- 5.1 Global Recombinant Trypsin Solution Revenue by Type
- 5.1.1 Global Recombinant Trypsin Solution Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Recombinant Trypsin Solution Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Recombinant Trypsin Solution Revenue Market Share by Type (2021-2032)
- 5.2 Global Recombinant Trypsin Solution Sales by Type
- 5.2.1 Global Recombinant Trypsin Solution Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Recombinant Trypsin Solution Sales by Type (2021-2032) & (K L)
- 5.2.3 Global Recombinant Trypsin Solution Sales Market Share by Type (2021-2032)
- 5.3 Global Recombinant Trypsin Solution Price by Type
6 Recombinant Trypsin Solution Market by Application
- 6.1 Global Recombinant Trypsin Solution Revenue by Application
- 6.1.1 Global Recombinant Trypsin Solution Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Recombinant Trypsin Solution Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Recombinant Trypsin Solution Revenue Market Share by Application (2021-2032)
- 6.2 Global Recombinant Trypsin Solution Sales by Application
- 6.2.1 Global Recombinant Trypsin Solution Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Recombinant Trypsin Solution Sales by Application (2021-2032) & (K L)
- 6.2.3 Global Recombinant Trypsin Solution Sales Market Share by Application (2021-2032)
- 6.3 Global Recombinant Trypsin Solution Price by Application
7 Company Profiles
- 7.1 Novozymes
- 7.1.1 Novozymes Company Information
- 7.1.2 Novozymes Business Overview
- 7.1.3 Novozymes Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Novozymes Recombinant Trypsin Solution Product Portfolio
- 7.1.5 Novozymes Recent Developments
- 7.2 BBI Group
- 7.2.1 BBI Group Company Information
- 7.2.2 BBI Group Business Overview
- 7.2.3 BBI Group Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 BBI Group Recombinant Trypsin Solution Product Portfolio
- 7.2.5 BBI Group Recent Developments
- 7.3 Roche
- 7.3.1 Roche Company Information
- 7.3.2 Roche Business Overview
- 7.3.3 Roche Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Roche Recombinant Trypsin Solution Product Portfolio
- 7.3.5 Roche Recent Developments
- 7.4 Thermo Fisher
- 7.4.1 Thermo Fisher Company Information
- 7.4.2 Thermo Fisher Business Overview
- 7.4.3 Thermo Fisher Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Thermo Fisher Recombinant Trypsin Solution Product Portfolio
- 7.4.5 Thermo Fisher Recent Developments
- 7.5 Merck
- 7.5.1 Merck Company Information
- 7.5.2 Merck Business Overview
- 7.5.3 Merck Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Merck Recombinant Trypsin Solution Product Portfolio
- 7.5.5 Merck Recent Developments
- 7.6 Applied Biotechnology Institute
- 7.6.1 Applied Biotechnology Institute Company Information
- 7.6.2 Applied Biotechnology Institute Business Overview
- 7.6.3 Applied Biotechnology Institute Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Applied Biotechnology Institute Recombinant Trypsin Solution Product Portfolio
- 7.6.5 Applied Biotechnology Institute Recent Developments
- 7.7 Biological Industries
- 7.7.1 Biological Industries Company Information
- 7.7.2 Biological Industries Business Overview
- 7.7.3 Biological Industries Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Biological Industries Recombinant Trypsin Solution Product Portfolio
- 7.7.5 Biological Industries Recent Developments
- 7.8 Yaxin Bio
- 7.8.1 Yaxin Bio Company Information
- 7.8.2 Yaxin Bio Business Overview
- 7.8.3 Yaxin Bio Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Yaxin Bio Recombinant Trypsin Solution Product Portfolio
- 7.8.5 Yaxin Bio Recent Developments
- 7.9 Yocon Hengye Bio
- 7.9.1 Yocon Hengye Bio Company Information
- 7.9.2 Yocon Hengye Bio Business Overview
- 7.9.3 Yocon Hengye Bio Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Yocon Hengye Bio Recombinant Trypsin Solution Product Portfolio
- 7.9.5 Yocon Hengye Bio Recent Developments
- 7.10 BasalMedia
- 7.10.1 BasalMedia Company Information
- 7.10.2 BasalMedia Business Overview
- 7.10.3 BasalMedia Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 BasalMedia Recombinant Trypsin Solution Product Portfolio
- 7.10.5 BasalMedia Recent Developments
- 7.11 Biosera
- 7.11.1 Biosera Company Information
- 7.11.2 Biosera Business Overview
- 7.11.3 Biosera Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Biosera Recombinant Trypsin Solution Product Portfolio
- 7.11.5 Biosera Recent Developments
8 North America
- 8.1 North America Recombinant Trypsin Solution Market Size by Type
- 8.1.1 North America Recombinant Trypsin Solution Revenue by Type (2021-2032)
- 8.1.2 North America Recombinant Trypsin Solution Sales by Type (2021-2032)
- 8.1.3 North America Recombinant Trypsin Solution Price by Type (2021-2032)
- 8.2 North America Recombinant Trypsin Solution Market Size by Application
- 8.2.1 North America Recombinant Trypsin Solution Revenue by Application (2021-2032)
- 8.2.2 North America Recombinant Trypsin Solution Sales by Application (2021-2032)
- 8.2.3 North America Recombinant Trypsin Solution Price by Application (2021-2032)
- 8.3 North America Recombinant Trypsin Solution Market Size by Country
- 8.3.1 North America Recombinant Trypsin Solution Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Recombinant Trypsin Solution Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Recombinant Trypsin Solution Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Recombinant Trypsin Solution Market Size by Type
- 9.1.1 Europe Recombinant Trypsin Solution Revenue by Type (2021-2032)
- 9.1.2 Europe Recombinant Trypsin Solution Sales by Type (2021-2032)
- 9.1.3 Europe Recombinant Trypsin Solution Price by Type (2021-2032)
- 9.2 Europe Recombinant Trypsin Solution Market Size by Application
- 9.2.1 Europe Recombinant Trypsin Solution Revenue by Application (2021-2032)
- 9.2.2 Europe Recombinant Trypsin Solution Sales by Application (2021-2032)
- 9.2.3 Europe Recombinant Trypsin Solution Price by Application (2021-2032)
- 9.3 Europe Recombinant Trypsin Solution Market Size by Country
- 9.3.1 Europe Recombinant Trypsin Solution Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Recombinant Trypsin Solution Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Recombinant Trypsin Solution Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Recombinant Trypsin Solution Market Size by Type
- 10.1.1 China Recombinant Trypsin Solution Revenue by Type (2021-2032)
- 10.1.2 China Recombinant Trypsin Solution Sales by Type (2021-2032)
- 10.1.3 China Recombinant Trypsin Solution Price by Type (2021-2032)
- 10.2 China Recombinant Trypsin Solution Market Size by Application
- 10.2.1 China Recombinant Trypsin Solution Revenue by Application (2021-2032)
- 10.2.2 China Recombinant Trypsin Solution Sales by Application (2021-2032)
- 10.2.3 China Recombinant Trypsin Solution Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Recombinant Trypsin Solution Market Size by Type
- 11.1.1 Asia Recombinant Trypsin Solution Revenue by Type (2021-2032)
- 11.1.2 Asia Recombinant Trypsin Solution Sales by Type (2021-2032)
- 11.1.3 Asia Recombinant Trypsin Solution Price by Type (2021-2032)
- 11.2 Asia Recombinant Trypsin Solution Market Size by Application
- 11.2.1 Asia Recombinant Trypsin Solution Revenue by Application (2021-2032)
- 11.2.2 Asia Recombinant Trypsin Solution Sales by Application (2021-2032)
- 11.2.3 Asia Recombinant Trypsin Solution Price by Application (2021-2032)
- 11.3 Asia Recombinant Trypsin Solution Market Size by Country
- 11.3.1 Asia Recombinant Trypsin Solution Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Recombinant Trypsin Solution Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Recombinant Trypsin Solution Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Recombinant Trypsin Solution Market Size by Type
- 12.1.1 SAMEA Recombinant Trypsin Solution Revenue by Type (2021-2032)
- 12.1.2 SAMEA Recombinant Trypsin Solution Sales by Type (2021-2032)
- 12.1.3 SAMEA Recombinant Trypsin Solution Price by Type (2021-2032)
- 12.2 SAMEA Recombinant Trypsin Solution Market Size by Application
- 12.2.1 SAMEA Recombinant Trypsin Solution Revenue by Application (2021-2032)
- 12.2.2 SAMEA Recombinant Trypsin Solution Sales by Application (2021-2032)
- 12.2.3 SAMEA Recombinant Trypsin Solution Price by Application (2021-2032)
- 12.3 SAMEA Recombinant Trypsin Solution Market Size by Country
- 12.3.1 SAMEA Recombinant Trypsin Solution Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Recombinant Trypsin Solution Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Recombinant Trypsin Solution Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Recombinant Trypsin Solution Value Chain Analysis
- 13.1.1 Recombinant Trypsin Solution Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Recombinant Trypsin Solution Production Mode & Process
- 13.2 Recombinant Trypsin Solution Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Recombinant Trypsin Solution Distributors
- 13.2.3 Recombinant Trypsin Solution Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst